As of November 2024, Immunovia AB has a market cap of $4.22M. This makes Immunovia AB the world's 34875th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $7.07M | -10.05% |
2023 | $7.86M | -93.26% |
2022 | $116.67M | -64.93% |
2021 | $332.72M | -37.08% |
2020 | $528.80M | -33.63% |
2019 | $796.75M | 30.33% |
2018 | $611.32M | 57.04% |
2017 | $389.28M | -4.62% |
2016 | $408.14M | 170.63% |
2015 | $150.81M | - |